高迁移率族蛋白N2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml高迁移率族蛋白N2抗体   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The high-mobility group (HMG) proteins 14 and 17 are abundant chromosomal proteins that bind to nucleosomes and enhance transcription (1–5). HMG-14 and HMG-17 also function as architectural elements, which alter the structure of the chromatin fiber and enhance transcription from chromatin templates (1–3,5). HMG-14/17 proteins modify the nucleosomal 高迁移率族蛋白N2抗体organization of the 30 nm chromatin fiber and mediate the unfolding of the higher order chromatin structure thereby facilitating access to the underlying DNA sequence (1–3). Clustering of architectural elements, such as HMG proteins and linker histone subtypes into distinct domains, may lead to structural and functional heterogeneity along the chromatin fiber (1–3).高迁移率族蛋白N2抗体 In addition, HMG-14 and HMG-17 have been identified as constitutive components of mouse oocyte and embryonic chromatin that establish a link between the structure of embryonic chromatin and the normal progression of embryonic development (2).

Also known as:

High mobility group (nonhistone chromosomal) protein 17; high mobility group nucleosomal binding domain 2; High mobility group nucleosome-binding domain-containing protein 2; High mobility group protein N2; HMG17; HMGN2; HMGN2_HUMAN; MGC5629; Non histone chromosomal高迁移率族蛋白N2抗体protein HMG 17; Non-histone chromosomal protein HMG-17; Nonhistone chromosomal protein HMG 17; nonhistone chromosomal protein hmg-17.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human HMGN2/HM.

●

高迁移率族蛋白N2抗体Predicted Molecular Weight: 9.2kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl004Ra01血管紧张素转化酶(ACE)多克隆抗体Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)

kl004Rb51血管紧张素转化酶(ACE)多克隆抗体Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE)

kl006Bo01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Eq01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Ga01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Hu01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Mu01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Po01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Ra01双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl006Rb51双调蛋白(AREG)多克隆抗体Polyclonal Antibody to Amphiregulin (AREG)

kl007Bo01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl007Eq01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl007Hu01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl007Mu01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl007Po01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl007Ra01血管生长素(ANG)多克隆抗体Polyclonal Antibody to Angiogenin (ANG)

kl008Bo01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)

kl008Ca01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)

kl008Ga01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)

kl008Hu01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)

kl008Mu01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)

kl008Po01血管生成素1(ANGPT1)多克隆抗体Polyclonal Antibody to Angiopoietin 1 (ANGPT1)